These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12535648)

  • 1. A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.
    Dumont N; Arteaga CL
    Biochem Biophys Res Commun; 2003 Jan; 301(1):108-12. PubMed ID: 12535648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells.
    Moore RK; Otsuka F; Shimasaki S
    J Biol Chem; 2003 Jan; 278(1):304-10. PubMed ID: 12419820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
    Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
    J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
    Pouliot F; Blais A; Labrie C
    Cancer Res; 2003 Jan; 63(2):277-81. PubMed ID: 12543773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Drosophila type II receptor, Wishful thinking, binds BMP and myoglianin to activate multiple TGFbeta family signaling pathways.
    Lee-Hoeflich ST; Zhao X; Mehra A; Attisano L
    FEBS Lett; 2005 Aug; 579(21):4615-21. PubMed ID: 16098524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway.
    Yue J; Hartsough MT; Frey RS; Frielle T; Mulder KM
    J Cell Physiol; 1999 Mar; 178(3):387-96. PubMed ID: 9989785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily.
    Knaus P; Sebald W
    Biol Chem; 2001 Aug; 382(8):1189-95. PubMed ID: 11592400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRAGON, a bone morphogenetic protein co-receptor.
    Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
    J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity.
    Le Roy C; Maisnier-Patin K; Leduque P; Li JY; Saez JM; Langlois D
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):87-98. PubMed ID: 10630409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta.
    Yue J; Frey RS; Mulder KM
    Oncogene; 1999 Mar; 18(11):2033-7. PubMed ID: 10208426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
    Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
    Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes.
    Hassel S; Schmitt S; Hartung A; Roth M; Nohe A; Petersen N; Ehrlich M; Henis YI; Sebald W; Knaus P
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():44-51. PubMed ID: 12925609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
    Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
    Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
    Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
    Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
    Buck MB; Pfizenmaier K; Knabbe C
    Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.